文献速递小儿麻醉心胸血管麻醉

小儿心脏手术体外循环预充:新鲜冰冻血浆与晶体液随机对照试验

Fresh Frozen Plasma versus Crystalloid Priming of Cardiopulmonary Bypass Circuit in Pediatric Surgery: A Randomized Clinical Trial.
PubMed 文献 · Anesthesiology · 2020-01-01

这项平行臂双盲随机对照试验纳入体重7至15 kg的先天性心脏病手术患儿,比较体外循环预充使用15 ml·kg新鲜冰冻血浆(FFP)或15 ml·kg晶体液(PlasmaLyte)对术后出血和输血需求的影响。结果显示,两组术后出血量、额外输血患者比例及输血制品数量均无显著差异,且无研究相关不良事件。

要点

  • 小儿体外循环预充用晶体液与FFP在术后出血和输血需求上无显著差异。
  • 两组额外输血比例分别为26.7%(FFP组)和37.9%(晶体液组),P=0.355。
  • 研究未观察到与研究相关的不良事件。

核心结论

  • 在婴幼儿和儿童中,体外循环预充使用晶体液与使用新鲜冰冻血浆相比,术后出血风险及需要输注异体血制品的风险无差异。

研究设计与样本

  • 平行臂双盲随机对照试验,纳入体重7至15 kg的先天性心脏病手术患儿,随机分为FFP预充组(30例)和晶体液预充组(29例),均额外加入预定量的浓缩红细胞。

主要发现

  • 术后中位出血量FFP组为7.1 ml·kg(5.1,9.4),晶体液组为5.7 ml·kg(3.8,8.5),P=0.219;差值(95%CI)为1.2(-0.7至3.2)。
  • 额外输血患者比例FFP组为26.7%(8/30),晶体液组为37.9%(11/29),P=0.355;比值比(95%CI)为1.7(0.6至5.1)。
  • 额外输注血制品数量中位数FFP组为0(0,1),晶体液组为0(0,2),P=0.254;差值(95%CI)为0(0至0)。
  • 未发生研究相关不良事件。

临床怎么用

  • 在小儿体外循环预充中,可考虑使用晶体液替代新鲜冰冻血浆,而不增加术后出血或输血风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In congenital cardiac surgery, priming cardiopulmonary bypass (CPB) with fresh frozen plasma (FFP) is performed to prevent coagulation abnormalities. The hypothesis was that CPB priming with crystalloids would be different compared with FFP in terms of bleeding and/or need for blood product transfusion. METHODS: In this parallel-arm double-blinded study, patients weighing between 7 and 15 kg were randomly assigned to a CPB priming with 15 ml · kg PlasmaLyte or 15 ml · kg FFP in addition to a predefined amount of packed red blood cells used in all patients. The decision to transfuse was clinical and guided by point-of-care tests. The primary endpoints included postoperative bleeding tracked by chest tubes, number of patients transfused with any additional blood products, and the total number of additional blood products administered intra- and postoperatively. The postoperative period included the first 6 h after intensive care unit arrival. RESULTS: Respectively, 30 and 29 patients in the FFP and in the crystalloid group were analyzed in an intention-to-treat basis. Median postoperative blood loss was 7.1 ml · kg (5.1, 9.4) in the FFP group and 5.7 ml · kg (3.8, 8.5) in the crystalloid group (P = 0.219); difference (95% CI): 1.2 (-0.7 to 3.2). The proportion of patients additionally transfused was 26.7% (8 of 30) and 37.9% (11 of 29) in the FFP and the crystalloid groups, respectively (P = 0.355; odds ratio [95% CI], 1.7 [0.6 to 5.1]). The median number of any blood products transfused in addition to priming was 0 (0, 1) and 0 (0, 2) in the FFP and crystalloid groups, respectively (P = 0.254; difference [95% CI], 0 [0 to 0]). There were no study-related adverse events. CONCLUSIONS: The results demonstrate that in infants and children, priming CPB with crystalloids does not result in a different risk of postoperative bleeding and need for transfusion of allogeneic blood products.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Dieu A, Rosal Martins M, Eeckhoudt S, et al. Fresh Frozen Plasma versus Crystalloid Priming of Cardiopulmonary Bypass Circuit in Pediatric Surgery: A Randomized Clinical Trial. Anesthesiology. 2020. PMID: 31658115. doi:10.1097/ALN.0000000000003017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。